Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19
Cláudia Gomes(New York University), Ana Rodrı́guez(Dr. Herbert & Nicole Wertheim Family Foundation), Marisol Zuniga(New York University), David C. Lee(New York University), Lawrence Hsu Lin(Harvard University), Kelly Crotty(New York University), María Fernanda Yasnot(University of Córdoba), Peter Izmirly(New York University), Jill P. Buyon(New York University), Paolo Cotzia(NYU Langone Health), Kun Qian(Chinese PLA General Hospital), Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Huilin Li(Changzhi Medical College), Robert M. Clancy(Columbia University Irving Medical Center), Nubia Catalina Tovar(University of Córdoba)
Cited by 27
Related Papers
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
|Journal of the American College of Cardiology|1998|748
Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
|Annals of the Rheumatic Diseases|2019|432